OrganaBio expands cell therapy manufacturing footprint with acquisition of Excellos Assets
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues
The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows
Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
Subscribe To Our Newsletter & Stay Updated